Open navigation menu
Close suggestions
Search
Search
en
Change Language
Language
English
(selected)
español
português
Deutsch
français
Русский
italiano
român
Bahasa Indonesia
Learn more
Upload
Read free for 30 days
Welcome to Scribd!
Upload
Language (EN)
Scribd Perks
Invite friends
FAQ and support
Sign in
Skip carousel
Carousel Previous
Carousel Next
What is Scribd?
Books
Audiobooks
Magazines
Podcasts
Sheet Music
Documents
Snapshots
Browse
Generic Drug
Generic Drug
Everything
Bestselling in Generic Drug
View More
Skip carousel
carousel previous
carousel next
Ucb et. al. v. Corepharma
Author
PriorSmart
Bottle of Lies: The Inside Story of the Generic Drug Boom
Author
Katherine Eban
Generic Alternatives to Prescription Drugs: Your Guide to Buying Effective Drugs at Cost-Saving Prices
Author
Diane Nitzki-George
Unimed Pharmaceuticals et. al. v. Perrigo Company et. al.
Author
PriorSmart
Dow Pharmaceutical Sciences et. al. v. Actavis et. al.
Author
PriorSmart
FDA Is Not the Problem: Why Undermining the Drug Approval Process Is Not the Answer to High Drug Prices
Author
Center for American Progress
Janssen Products et. al. v. Lupin et. al.
Author
PriorSmart
Generic Challenge:: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Fifth Edition)
Author
Martin a. Voet
Ferring v. Mylan et. al.
Author
PriorSmart
Oral Drug Delivery Technology
Author
Aukunuru Jithan
Bill Ackman Allergan Presentation
Author
CanadianValue
Novartis Pharmaceuticals v. Torrent Pharmaceuticals et. al.
Author
PriorSmart
NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): An Overview
Author
Swarnlata Saraf
Generic Drugs: A Consumer’S Self-Defense Guide
Author
Clifford L. Nilsen
Forest Laboratories et. al. v. Torrent Pharmaceuticals et. al.
Author
PriorSmart
SENATE HEARING, 110TH CONGRESS - FINANCIAL SERVICES AND GENERAL GOVERNMENT APPROPRIATIONS FOR FISCAL YEAR 2009
Author
Scribd Government Docs
Alza v. Mylan Pharmaceuticals et. al.
Author
PriorSmart
09-24-15 Edition
Author
San Mateo Daily Journal
Price Watch Trends in Retail Prices of Specialty Prescription Drugs 2006 to 2013 Nov
Author
Zerohedge
CEI Planet - May-June 2011
Author
Competitive Enterprise Institute
Helsinn Healthcare et. al. v. Dr. Reddy's Laboratories et. al.
Author
PriorSmart
AstraZeneca AB v. Mylan Pharmaceuticals
Author
PriorSmart
SENATE HEARING, 109TH CONGRESS - INCREASING GENERIC DRUG USE: SAVINGS FOR SENIORS AND MEDICARE
Author
Scribd Government Docs
Recordati Rare Diseases v. Exela Pharma Sciences et. al.
Author
PriorSmart
Patent Monopolies and the Costs of Mismarketing Drugs
Author
Center for Economic and Policy Research
Novartis Pharmaceuticals et. al. v. Mylan et. al.
Author
PriorSmart
HOUSE HEARING, 110TH CONGRESS - ASSESSING THE IMPACT OF A SAFE AND EQUITABLE BIOSIMILAR POLICY IN THE UNITED STATES
Author
Scribd Government Docs
05-08-15 edition
Author
San Mateo Daily Journal
Dare to Lead: Public health and company wealth
Author
Oxfam
Cadence Pharmaceuticals et. al. v. Paddock Laboratories et. al.
Author
PriorSmart
Everything About Generic Drug
View More
Skip carousel
carousel previous
carousel next
Senate Aging Report Sudden Price Spikes in Off Patent Prescription Drugs
Author
kmccoynyc
Janssen Products et. al. v. Lupin et. al.
Author
PriorSmart
HOUSE HEARING, 109TH CONGRESS - INCREASING GENERIC DRUG UTILIZATION: SAVING MONEY FOR PATIENTS
Author
Scribd Government Docs
SENATE HEARING, 110TH CONGRESS - POLICY IMPLICATIONS OF PHARMACEUTICAL IMPORTATION FOR U.S. CONSUMERS
Author
Scribd Government Docs
Generic Challenge:: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (Fifth Edition)
Author
Martin a. Voet
Oral Drug Delivery Technology
Author
Aukunuru Jithan
Bill Ackman Allergan Presentation
Author
CanadianValue
Generic drug maker Complaint Final (Redacted Public Version) 12 15 16
Author
Matthew Hamilton
Demonizing Drugmakers: The Political Assault on the Pharmaceutical Industry, Cato Policy Analysis No. 475
Author
Cato Institute
NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): An Overview
Author
Swarnlata Saraf
Generic Drugs: A Consumer’S Self-Defense Guide
Author
Clifford L. Nilsen
Fatal Side Effects: Medicine patents under the microscope
Author
Oxfam
HOUSE HEARING, 112TH CONGRESS - REVIEW OF THE PROPOSED GENERIC DRUG AND BIOSIMILARS USER FEES AND FURTHER EXAMINATION OF DRUG SHORTAGES
Author
Scribd Government Docs
Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines
Author
Oxfam
FDA Is Not the Problem: Why Undermining the Drug Approval Process Is Not the Answer to High Drug Prices
Author
Center for American Progress
SENATE HEARING, 108TH CONGRESS - LEGISLATIVE AND REGULATORY RESPONSES TO THE FTC STUDY ON BARRIERS TO ENTRY IN THE PHARMACEUTICAL MARKETPLACE
Author
Scribd Government Docs
09-24-15 Edition
Author
San Mateo Daily Journal
Fatal Side Effects: Medicine patents under the microscope
Author
Oxfam
Patent Injustice: How world trade rules threaten the health of poor people
Author
Oxfam
05-08-15 edition
Author
San Mateo Daily Journal
Patent Injustice: How world trade rules threaten the health of poor people
Author
Oxfam
Senju Pharmaceutical et. al. v. Metrics et. al.
Author
PriorSmart
Dare to Lead: Public health and company wealth
Author
Oxfam
Dare to Lead: Public health and company wealth
Author
Oxfam
Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines
Author
Oxfam
Patent Injustice: How world trade rules threaten the health of poor people
Author
Oxfam
Abbott Laboratories et. al. v. Watson Pharmaceuticals et. al.
Author
PriorSmart
Cutting the Cost of Global Health
Author
Oxfam
Otsuka Pharmaceutical v. Hetero et. al.
Author
PriorSmart
Niaspan Lawsuit Complaint
Author
Southern California Public Radio
Recently Added
View More
Skip carousel
carousel previous
carousel next
Oral Drug Delivery Technology
Author
Aukunuru Jithan
NSAIDs (Nonsteroidal Anti-Inflammatory Drugs): An Overview
Author
Swarnlata Saraf
Generic Drugs: A Consumer’S Self-Defense Guide
Author
Clifford L. Nilsen
Bill Ackman Allergan Presentation
Author
CanadianValue
SENATE HEARING, 107TH CONGRESS - CLOSING THE GAPS IN HATCH-WAXMAN: ASSURING GREATER ACCESS TO AFFORDABLE PHARMACEUTICALS
Author
Scribd Government Docs
SENATE HEARING, 108TH CONGRESS - EXAMINING THE SENATE AND HOUSE VERSIONS OF THE ``GREATER ACCESS TO AFFORDABLE PHARMACEUTICALS ACT''
Author
Scribd Government Docs
Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines
Author
Oxfam
Eye on the Ball: Medicine regulation - not IP enforcement - can best deliver quality medicine
Author
Oxfam
US Bullying on Drug Patents: One year after Doha
Author
Oxfam
Undermining Access to Medicines: Comparison of five US FTAs: A technical note
Author
Oxfam
TRIPS and Public Health: The next battle
Author
Oxfam
Investing For Life: Meeting poor people's needs for access to medicines through responsible business practices
Author
Oxfam
Song of the Sirens: Why the US–Andean FTAs undermine sustainable development and regional integration
Author
Oxfam
Robbing the Poor to Pay the Rich? How the United States keeps medicines from the world’s poorest
Author
Oxfam
Public Health at Risk: A US free trade agreement could threaten access to medicines in Thailand
Author
Oxfam
Free Trade Agreement Between the USA and Thailand Threatens Access to HIV/AIDS Treatment
Author
Oxfam
Generic Competition, Price and Access to Medicines: The case of antiretrovirals in Uganda
Author
Oxfam
Drug Companies vs. Brazil: The threat to public health
Author
Oxfam
All Costs, No Benefits: How TRIPS plus intellectual property rules in the US-Jordan FTA affect access to medicines
Author
Oxfam
Thailand: American Bullying Puts Pharmaceutical Company Profits before the Health of Millions
Author
Oxfam
Patent Injustice: How world trade rules threaten the health of poor people
Author
Oxfam
Dare to Lead: Public health and company wealth
Author
Oxfam
Cutting the Cost of Global Health
Author
Oxfam
Fatal Side Effects: Medicine patents under the microscope
Author
Oxfam
Make Vital Medicines Available for Poor People: Dominican Republic
Author
Oxfam
Access to Antiretroviral Therapy in Uganda: Kampala, June 2002
Author
Oxfam
Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines
Author
Oxfam
Eye on the Ball: Medicine regulation - not IP enforcement - can best deliver quality medicine
Author
Oxfam
US Bullying on Drug Patents: One year after Doha
Author
Oxfam
Undermining Access to Medicines: Comparison of five US FTAs: A technical note
Author
Oxfam
View All In Generic Drug
Loading
Quick navigation
Home
Books
Audiobooks
Documents